| Name | Highmore Health |
|---|---|
| Location | 410 8th Street Se, Highmore, South Dakota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 40 |
| Occupancy Rate | 93.5% |
| Medicare ID (CCN) | 435092 |
| Legal Business Name | Highmore Nursing Home, Inc. |
| Ownership Type | For Profit - Individual |
| NPI Number | 1851619720 |
| Organization Name | HIGHMORE NURSING HOME, INC. |
| Doing Business As | HIGHMORE HEALTH |
| Address | 410 8th Street Se, Highmore, SD 57345 |
| Phone Number | 605-852-2255 |
News Archive
An examination of the benefit of preventive placement of implantable cardioverter-defibrillators (ICDs) in patients with a less severe level of heart failure, a group not well represented in clinical trials, finds significantly better survival at three years than that of similar patients with no ICD, according to a study in the June 4 issue of JAMA.
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on MedeFile International after releasing the latest short sale data through May 27, 2010. The total aggregate number of shares shorted since August 2009 is approximately 1.75 billion shares.
Cognitive Science represents the exploration of the human mind in the hope of answering some of humanity's oldest questions, from the origin of thought to the nature of knowledge. Today cognitive scientists link these ancient questions to the newest emerging fields of research in various areas, an approach epitomized by WIREs Cognitive Science, the latest interdisciplinary project from Wiley-Blackwell.
Just listening to Irene Ingemi describe the patchwork system of friends, family, and part-time day-care services she's stitched together to help her care for her frail mother-in-law is exhausting.
Otsuka Pharmaceutical Co., Ltd. and Otsuka Holdings, Co., Ltd., the parent company of Otsuka Pharmaceutical Co., Ltd., announced today that the U.S. District Court for the District of New Jersey issued its judgment dated November 15, 2010 in favor of Otsuka Pharmaceutical Co., Ltd. in its patent litigation against several companies seeking FDA approval to market generic copies of Abilify.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
An examination of the benefit of preventive placement of implantable cardioverter-defibrillators (ICDs) in patients with a less severe level of heart failure, a group not well represented in clinical trials, finds significantly better survival at three years than that of similar patients with no ICD, according to a study in the June 4 issue of JAMA.
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on MedeFile International after releasing the latest short sale data through May 27, 2010. The total aggregate number of shares shorted since August 2009 is approximately 1.75 billion shares.
Cognitive Science represents the exploration of the human mind in the hope of answering some of humanity's oldest questions, from the origin of thought to the nature of knowledge. Today cognitive scientists link these ancient questions to the newest emerging fields of research in various areas, an approach epitomized by WIREs Cognitive Science, the latest interdisciplinary project from Wiley-Blackwell.
Just listening to Irene Ingemi describe the patchwork system of friends, family, and part-time day-care services she's stitched together to help her care for her frail mother-in-law is exhausting.
Otsuka Pharmaceutical Co., Ltd. and Otsuka Holdings, Co., Ltd., the parent company of Otsuka Pharmaceutical Co., Ltd., announced today that the U.S. District Court for the District of New Jersey issued its judgment dated November 15, 2010 in favor of Otsuka Pharmaceutical Co., Ltd. in its patent litigation against several companies seeking FDA approval to market generic copies of Abilify.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 23.88 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 2.99 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 59.52 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 6.66 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.7 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 12.69 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.65 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.89 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.14 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.43 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.7 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 17.65 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.58 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 87.9 | 95.98 |